Vulnerability in Smiths-Medical Medfusion 4000 Wireless Syringe Infusion Pump
CVE-2017-12721
- CVSS v3
- 5.9 Medium
- Public exploits
- None known
- EPSS
- 0.007 · 52.7th percentile
- Published
- 2018-02-15
An Improper Certificate Validation issue was discovered in Smiths Medical Medfusion 4000 Wireless Syringe Infusion Pump, Version 1.1, 1.5, and 1.6. The pump does not validate host certificates, leaving the pump vulnerable to a man-in-the-middle (MITM) attack.
Vulnerability class: Improper Certificate Validation
Published · last modified .
CVSS v3 metric
CVSS v3 base score 5.9 (Medium). Vector: CVSS:3.0/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:N/A:N.
- Attack Vector
- Network
AV:N - Attack Complexity
- High
AC:H - Privileges Required
- None
PR:N - User Interaction
- None
UI:N - Scope
- Unchanged
S:U - Confidentiality
- High
C:H - Integrity
- None
I:N - Availability
- None
A:N
EPSS exploit prediction
EPSS 0.007, 52.7th percentile (last changed ); unchanged over 30 days. About EPSS.
Affected products
- Smiths-Medical Medfusion 4000 Wireless Syringe Infusion Pump — versions 1.1, 1.5, 1.6
- Smiths Medical Medfusion 4000 Wireless Syringe Infusion Pump — versions Smiths Medical Medfusion 4000 Wireless Syringe Infusion Pump
Weakness classification (CWE)
References
- ics-cert.us-cert.gov/advisories/ICSMA-17-250-02A (US Government Resource, Third Party Advisory)
- www.securityfocus.com/bid/100665 (Third Party Advisory, VDB Entry, vdb-entry)